What is Nuwellis, Inc.'s market cap?

Nuwellis, Inc. (NUWE) has a market capitalization of $265.5K and trades on NASDAQ.

Who are Nuwellis, Inc.'s competitors?

Nuwellis, Inc.'s key competitors include Baxter International, Medtronic, Outset Medical, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Nuwellis, Inc. partner with?

Nuwellis, Inc.'s notable partners include KDI Precision Manufacturing, Baxter International, Medtronic, and others.

Where is Nuwellis, Inc. headquartered?

Nuwellis, Inc. is headquartered in United States of America and employs approximately 59 people. It has been publicly traded since 2012.

Nuwellis, Inc.

NUWE

Nuwellis is a medical technology company dedicated to advancing cardiorenal care through innovative fluid management solutions.

Market cap

$265.54K-99.5%

Table of contents

Earnings

Q1 2026 report

May 12, 2026

Revenue$2.4MBeat by $309.0K EPS-$2.09Miss by $1.09

Read the full report

Next report

Aug 13, 2026 (in a month)

Revenue estimate$2.4M

EPS estimate-$23.80

Competitors

By market cap

Medtronic$105.46B-6.1%

Baxter International$11.6B-23.9%

ICU Medical$3.9B+22.5%

InfuSystem Holdings$196.6M+49.9%

Outset Medical, Inc.$82.5M-77.2%

Cytosorbents$23.4M-63.7%

SeaStar Medical Holding Corporation$19.6M-77.9%

Nuwellis, Inc.$265.5K-99.5%

By revenue growth

Medtronic+8.4%

Baxter International+5.1%

InfuSystem Holdings+3.5%

Outset Medical, Inc.+2.0%

ICU Medical-10.9%

By net margin

Medtronic13.2%-0.7pp

InfuSystem Holdings5.56%+3.2pp

ICU Medical-0.317%+7.0pp

Baxter International-9.7%-4.5pp

Outset Medical, Inc.-63.65%+35.1pp

Profile

Nuwellis is a medical technology company dedicated to advancing cardiorenal care through innovative fluid management solutions. The company develops, manufactures, and commercializes ultrafiltration systems designed to safely and precisely remove excess salt and water from patients suffering from fluid overload. Its core value proposition centers on providing a controlled alternative to diuretic therapy for patients who are unresponsive to traditional medical management.

Competitive position

Nuwellis is a specialized provider of ultrafiltration technology, positioning itself as a superior alternative to the standard-of-care pharmacological treatments (diuretics) for fluid overload.

GeographiesUnited States, Singapore, Hong Kong, Israel, Brazil

Customer segmentsHospitals, Specialized Medical Centers, Outpatient Departments

Business modelMedical Device Manufacturing, Razor-and-Blade (Capital Equipment and Disposables)

SuppliersThird-party component manufacturers, Contract manufacturing organizations, Specialized medical-grade material suppliers

CustomersAcute care hospitals, Academic medical centers, Outpatient infusion clinics, Pediatric specialty hospitals

CountryUnited States of America

Listed2012

Employees59.0

CEOJohn Erb

SectorHealthcare

IndustryMedical - Devices

Websitenuwellis.com

FilingsSEC EDGAR

Questions, answered.

What is Nuwellis, Inc.'s market cap?: Nuwellis, Inc. (NUWE) has a market capitalization of $265.5K and trades on NASDAQ.
Who are Nuwellis, Inc.'s competitors?: Nuwellis, Inc.'s key competitors include Baxter International, Medtronic, Outset Medical, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Nuwellis, Inc. partner with?: Nuwellis, Inc.'s notable partners include KDI Precision Manufacturing, Baxter International, Medtronic, and others.
Where is Nuwellis, Inc. headquartered?: Nuwellis, Inc. is headquartered in United States of America and employs approximately 59 people. It has been publicly traded since 2012.